Discover the detailed record of transactions filed by Cline Christopher R.. Director active across 1 company, notably Travere Therapeutics, Inc.. In total, 26 reports have been recorded. Split: 0 buy · 17 sells. Total volume traded: €450k. Activity tracked since 1 September 2022. The latest transaction was disclosed on 2 September 2026 (Cession). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Cline Christopher R.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Cline Christopher R. is Chief Financial Officer at Travere Therapeutics, Inc. The record shows 25 filings, and across the recent sampled filings from 2022-09-01 to 2026-04-15, the dominant transaction nature is sell, with sum_buy_eur at 0 and sum_sell_eur at 413664.